Company profile

Heron Therapeutics, Inc. /de/ Insider Trading

HRTX

Every SEC Form 4 insider trading filing for Heron Therapeutics, Inc. /de/ (HRTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0000818033
Filings
119
Insiders
17
Last filing
2026-08-06

Activity summary

Recent insider activity is bullish. Over the last 30 days, 16 insiders purchased shares versus 5 sales. Buying was led by Hensley Mark Earl.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. Heron Therapeutics, Inc. /de/ insiders are net buyers across the period shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $8.7M.

90 day insight

Over the last 90 days, Heron Therapeutics, Inc. /de/ insiders bought $0 (26 transactions) and sold $14K (8 transactions).

  • Most active insider: Duarte Ira with 12 transactions totaling $5K.
  • Largest single sale: $4K by Hensley Mark Earl on Aug 6, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 6, 2026Hensley Mark EarlHRTX
Tax Withholding
8,888$0.50$4K
Aug 6, 2026Hensley Mark EarlHRTX
Option Exercise
31,250
Aug 6, 2026Hensley Mark EarlHRTX
Option Exercise
31,250
Jul 31, 2026Hensley Mark EarlHRTX
Option Exercise
11,769
Jul 31, 2026Duarte IraHRTX
Option Exercise
11,694

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=HRTX" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Duarte IraEVP, Chief Financial Officer4 filings$5K
Hensley Mark EarlChief Operating Officer1 filing$4K
Forbes William PEVP, Chief Development Officer3 filings$4K

Institutional Ownership

Top 13F-HR holders of Heron Therapeutics, Inc. /de/ as of 2026-06-30

↓ decreasing
Total reported AUM
$10.5M
QoQ change
-91.6%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$2.7M
6.4M shares
#2
JW Asset Management, LLC
CIK 0001549738
$1.6M
3.8M shares
#3
BlackRock, Inc.
CIK 0002012383
$1.4M
3.3M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →